A study to evaluate risk factors and factors associated with non-adherence to the prescribed treatment among essential hypertensive patients attending tertiary care hospital

Venkat Sunil Bommishetty, Suresh Keshav Kumbhar


Background: Prevalence of hypertension is on rising trend with rise in life style and behavioral changes. It is also a major risk factor for most of the dreadful conditions like coronary artery disease, stroke, etc. Medication adherence would help in reducing the chance of occurrence of such complications. Thus objectives of study are 1) to evaluate the risk factors of hypertension among the diagnosed essential hypertensive patients; and 2) to assess the magnitude and the factors associated with non-adherence to the prescribed treatment.

Methods: A hospital based cross-sectional study among 71 participants was conducted, using a pre-structured questionnaire and physical examination to assess risk factors of hypertension and CULIG’s 16 questionnaire medication adherence scale to assess the non-adherence. Data analysed with proportions and Chi square test.

Results: Out of 71 participants, 60 (84.5%) were found to be non-adherent to their anti-hypertensive medication and factors like being male (p=0.0055), alcohol consumption (p=0.0485) and paid medication (p=0.0091) were found to be significantly affecting the medication non-adherence. Positive family history, sedentary life style, preference of extra salt and smoking/tobacco products usage were the most common risk factors of essential hypertension observed along with others.

Conclusions: The participants who experienced the complications/ill effects of hypertension were more adherent as compared to others. Factors which are responsible for non -adherence need to be addressed and appropriate interventions required to improve adherence by educating the people about its importance in prevention of complications.


Behavioural changes, CULIG’s scale, Essential hypertension, Life-style, Non-adherence

Full Text:



Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2224-60.

Campbell NRC, Lackland DT, Niebylski ML. World Hypertension League Committee; International Society of Hypertension Executive Committee. High Blood Pressure: Why prevention and control are urgent and important- a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens. 2014;16(8):551-3.

Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287(8):1003-10.

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.

Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000;18(5):521-9.

Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513-8.

Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27(7):1472-7.

Karan A, Engel au M, Mahal A. The household-level economic burden of heart disease in India. Trop Med Int Health. 2014;19(5):581-91.

Sabaté E, ed. defining adherence. In: Adherence to Long-Term Therapies- Evidence for Action. World Health Organization. Geneva: WHO Press; 2003:3.

Ho MP, Bryson CL, Rumsfeld JS. Medication adherence: it’s importance in cardiovascular outcomes. Circulation. 2009;119:3028-35.

Venkatachalam J, Abraham SB, Singh Z, Stalin P, Sathya GR. Determinants of patients adherence to hypertension medications in a rural population of Kancheepuram District in Tamil Nadu, South India. Indian J Community Med. 2015;40(1):33-7.

Culig J, Leppee M. From Morisky to Hill-Bone; self-reports scales for measuring adherence to medication. Collegium Antropologium. 2014;38(1):55-62.

Bansal SK, Saxena V, Kandpal SD, Gray WK, Walker RW, Goel D. The prevalence of hypertension and hypertension risk factors in a rural Indian community: A prospective door-to-door study. J Cardiovasc Dis Res. 2012;3(2):117-23.

Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. Int J Hypertens. 2017;5491838.

Hema K, Padmalatha P. Adherence to medication among hypertensive patients attending a tertiary care hospital in Guntur, Andhra Pradesh. Indian J Basic Applied Med Res. 2014;4(1):451-6.

Rao BB, Kabra PR, Sreedhar M. Factors associated with adherence to antihypertensive treatment among hypertensive persons in an urban slum area of Hyderabad. Indian J Basic Applied Med Res. 2014;4(1):471-7.

Kumaraswamy RC, Kauser MM, Jagadeesh MK, Kumar RU, Kumar SRV, Afreen A, et al. Study of determinants of non-adherence to anti-hypertensive medications in essential hypertension at a teaching hospital in Southern India. Chrismed J Health. 2015;4(1):57-60.

Rao CR, Kamath VG, Shetty A, Kamath A. Treatment compliance among patients with hypertension and type 2 diabetes mellitus in a coastal population of Southern India. Int J Prev Med. 2014;5(8):992-8.

Teshome DF, Bekele KB, Habitu YA, Gelagay AA. Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia. Integrat Blood Pressure Control. 2017;10:1.

Khanam MA, Lindeboom W, Koehlmoos TLP, Alam DS, Niessen L, Milton AH. Hypertension: adherence to treatment in rural Bangladesh findings from a population-based study. Glob Health Action. 2014;7:25028.

Iloh GUP, Ofoedu JN, Njoku PU, Amadi AN, Godswill UEU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr J Prm Health Care Fam Med. 2013;5(1):446.

Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J. et al. High rates of nonadherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014;100(11):855-61.

Lin YP, Huang YH, Yang YC, Wu JS, Chang CJ, Lu FH. Adherence to antihypertensive medications among the elderly: a community-based survey in Tainan city, Southern Taiwan. Taiwan Geriatr Gerontol. 2007;2(3):176-89.